Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-055702
Filing Date
2021-11-09
Accepted
2021-11-09 16:02:30
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FRLN Q3-2021 6K-IXBRL frln-6k_20210930.htm   iXBRL 6-K 2008556
2 EX-99.1 frln-ex991_470.htm EX-99.1 237998
3 GRAPHIC gdb3xuebwqsw000001.jpg GRAPHIC 48668
  Complete submission text file 0001564590-21-055702.txt   6838606

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA frln-20210930.xsd EX-101.SCH 49705
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE frln-20210930_cal.xml EX-101.CAL 45691
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE frln-20210930_def.xml EX-101.DEF 167415
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE frln-20210930_lab.xml EX-101.LAB 359618
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE frln-20210930_pre.xml EX-101.PRE 285812
9 EXTRACTED XBRL INSTANCE DOCUMENT frln-6k_20210930_htm.xml XML 1050568
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 211391965
SIC: 2836 Biological Products, (No Diagnostic Substances)